Oral Antibiotic Recommendations for Questionable Wound Infection with Uncertain History
For a wound infection of uncertain severity with possible penicillin allergy or MRSA risk, start with clindamycin 300-450 mg orally every 6 hours for 5 days, as it provides single-agent coverage for both streptococci and MRSA without requiring combination therapy, but only if local MRSA clindamycin resistance rates are <10%. 1
Primary Decision Algorithm
Step 1: Assess MRSA Risk Factors
Step 2: Determine Allergy Status
For true penicillin allergy (immediate hypersensitivity): 1
For questionable or non-immediate penicillin allergy: 1
Step 3: Select Antibiotic Based on Risk Profile
For Non-Purulent Wounds WITHOUT MRSA Risk Factors:
- First-line: Cephalexin 500 mg orally every 6 hours for 5 days 2, 1
- Alternative (if penicillin/cephalosporin allergy): Clindamycin 300-450 mg every 6 hours for 5 days 1
- Beta-lactam monotherapy is successful in 96% of typical cellulitis cases 1
For Purulent Wounds OR Confirmed MRSA Risk:
- First-line: Clindamycin 300-450 mg orally every 6 hours for 5 days 2, 1
- Alternative combination: Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS cephalexin 500 mg every 6 hours 1
- Alternative combination: Doxycycline 100 mg twice daily PLUS cephalexin 500 mg every 6 hours 1
Critical caveat: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for wound infections, as their activity against beta-hemolytic streptococci is unreliable 1
For Bite-Related Wounds (Animal or Human):
- First-line: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 2, 5
- Alternative (if penicillin allergic): Doxycycline 100 mg twice daily PLUS clindamycin 300 mg every 6 hours 1
Treatment Duration
- Standard duration: 5 days if clinical improvement occurs 2, 1
- Extend treatment ONLY if symptoms have not improved within 5 days 1
- Do not reflexively extend to 7-10 days based on residual erythema alone, as some inflammation persists even after bacterial eradication 1
When to Escalate or Hospitalize
Immediate hospitalization and IV antibiotics are required if: 1
- Systemic inflammatory response syndrome (fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm) 1
- Hypotension or altered mental status 1
- Severe pain out of proportion to examination findings 1
- Rapid progression or "wooden-hard" subcutaneous tissues suggesting necrotizing infection 1
For hospitalized patients requiring IV therapy: Vancomycin 15-20 mg/kg IV every 8-12 hours is first-line (A-I evidence) 1
Common Pitfalls to Avoid
- Do not add MRSA coverage reflexively without specific risk factors — this represents overtreatment and increases antibiotic resistance 1
- Do not use fluoroquinolones (levofloxacin) as first-line — reserve for beta-lactam allergies, as they lack adequate MRSA coverage and promote resistance 3
- Do not prescribe antibiotics without addressing source control — any abscess requires incision and drainage as primary treatment 1, 5
- Do not use amoxicillin-clavulanate for purulent cellulitis requiring MRSA coverage — it lacks anti-MRSA activity 1